Literature DB >> 33308323

Solid component ratio influences prognosis of GGO-featured IA stage invasive lung adenocarcinoma.

Fenghao Sun1, Yiwei Huang1, Xiaodong Yang1, Cheng Zhan1, Junjie Xi1, Zongwu Lin1, Yu Shi1, Wei Jiang1, Qun Wang2.   

Abstract

BACKGROUND: The computed tomography (CT) characteristic of ground glass opacity (GGO) were shown to be associated with clinical significance in lung adenocarcinoma. We evaluated the prognostic value of the solid component ratio of GGO IA invasive lung adenocarcinoma.
METHODS: We retrospectively analyzed the records of GGO IA patients who received surgical resection from April 2012 to December 2015. The solid component ratio was calculated based on thin-slice CT scans. Baseline features were compared stratified by the ratio. Cox proportional hazard models and survival analyses were adopted to explore potential prognostic value regarding overall survival (OS) and disease-free survival (DFS).
RESULTS: Four hundred fifteen patients were included. The higher ratio was significantly associated with larger tumor diameter, pathological subtypes and choice of surgical type. There was a significantly worse DFS with a > 50% ratio. The subgroups of 0% and ≤ 50% ratio showed close survival curves of DFS. Similar trends were observed in OS. Multivariate analyses revealed that the ratio was a significant predictor for DFS, but not for OS. No significant prognostic difference was observed between lobectomy and limited resections.
CONCLUSION: A higher solid component ratio may help to predict a significantly worse prognosis of GGO IA lung adenocarcinoma.

Entities:  

Keywords:  Ground glass opacity; Lung adenocarcinoma; Prognosis; Solid component ratio

Year:  2020        PMID: 33308323     DOI: 10.1186/s40644-020-00363-6

Source DB:  PubMed          Journal:  Cancer Imaging        ISSN: 1470-7330            Impact factor:   3.909


  3 in total

1.  miR-17-5p/HOXA7 Is a Potential Driver for Brain Metastasis of Lung Adenocarcinoma Related to Ferroptosis Revealed by Bioinformatic Analysis.

Authors:  Quanfang Chen; Qingyun Pan; Han Gao; Yingju Wang; Xiaoning Zhong
Journal:  Front Neurol       Date:  2022-05-25       Impact factor: 4.086

2.  Ground Glass Opacity and Adjuvant Chemotherapy in Pathological Stage IB-IIA Lung Adenocarcinoma.

Authors:  Wenyu Zhai; Li Gong; Yuzhen Zheng; Qihang Yan; Renchun Lai; Dachuan Liang; Wingshing Wong; Shuqin Dai; Junye Wang
Journal:  Front Oncol       Date:  2022-03-25       Impact factor: 6.244

3.  Construction of Pulmonary Nodule CT Radiomics Random Forest Model Based on Artificial Intelligence Software for STAS Evaluation of Stage IA Lung Adenocarcinoma.

Authors:  Qian Liu; Wanyin Qi; Yanping Wu; Yingjun Zhou; Zhiwei Huang
Journal:  Comput Math Methods Med       Date:  2022-08-28       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.